Diabetes and COVID-19: Ten Questions

The COVID-19 pandemic is now an international concern. COVID-19 is first reported in Wuhan, China on 31 December 2019 and affects different people in different ways. Evidence suggests that people with underlying disease are at higher risk for more severe disease. People with diabetes are not only m...

Full description

Bibliographic Details
Main Authors: Mahbube Ebrahimpur, Moloud Payab, Mahnaz Pejman Sani, Bagher Larijani
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2020-06-01
Series:Advanced Journal of Emergency Medicine
Subjects:
Online Access:http://ajem.tums.ac.ir/index.php/ajem/article/view/442
id doaj-810665129f05478d9ef3ff0cbe3a6697
record_format Article
spelling doaj-810665129f05478d9ef3ff0cbe3a66972020-11-25T02:58:51ZengTehran University of Medical SciencesAdvanced Journal of Emergency Medicine2588-400X2020-06-0110.22114/ajem.v0i0.442Diabetes and COVID-19: Ten QuestionsMahbube Ebrahimpur0Moloud Payab1Mahnaz Pejman Sani2Bagher Larijani3Elderly Health Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, IranObesity and Eating Habits Research Center, Endocrinology and Metabolism Molecular -Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, IranDepartment of Internal Medicine, Shariati Hospital, Tehran University of Medical Sciences, Tehran, IranEndocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran The COVID-19 pandemic is now an international concern. COVID-19 is first reported in Wuhan, China on 31 December 2019 and affects different people in different ways. Evidence suggests that people with underlying disease are at higher risk for more severe disease. People with diabetes are not only more likely than the general population to have COVID-19 but also they are among those high-risk categories that can have serious illness if they get the virus. http://ajem.tums.ac.ir/index.php/ajem/article/view/442Clinical ManagementCOVID-19DiabetesPathogenesisSARS-CoV-2
collection DOAJ
language English
format Article
sources DOAJ
author Mahbube Ebrahimpur
Moloud Payab
Mahnaz Pejman Sani
Bagher Larijani
spellingShingle Mahbube Ebrahimpur
Moloud Payab
Mahnaz Pejman Sani
Bagher Larijani
Diabetes and COVID-19: Ten Questions
Advanced Journal of Emergency Medicine
Clinical Management
COVID-19
Diabetes
Pathogenesis
SARS-CoV-2
author_facet Mahbube Ebrahimpur
Moloud Payab
Mahnaz Pejman Sani
Bagher Larijani
author_sort Mahbube Ebrahimpur
title Diabetes and COVID-19: Ten Questions
title_short Diabetes and COVID-19: Ten Questions
title_full Diabetes and COVID-19: Ten Questions
title_fullStr Diabetes and COVID-19: Ten Questions
title_full_unstemmed Diabetes and COVID-19: Ten Questions
title_sort diabetes and covid-19: ten questions
publisher Tehran University of Medical Sciences
series Advanced Journal of Emergency Medicine
issn 2588-400X
publishDate 2020-06-01
description The COVID-19 pandemic is now an international concern. COVID-19 is first reported in Wuhan, China on 31 December 2019 and affects different people in different ways. Evidence suggests that people with underlying disease are at higher risk for more severe disease. People with diabetes are not only more likely than the general population to have COVID-19 but also they are among those high-risk categories that can have serious illness if they get the virus.
topic Clinical Management
COVID-19
Diabetes
Pathogenesis
SARS-CoV-2
url http://ajem.tums.ac.ir/index.php/ajem/article/view/442
work_keys_str_mv AT mahbubeebrahimpur diabetesandcovid19tenquestions
AT moloudpayab diabetesandcovid19tenquestions
AT mahnazpejmansani diabetesandcovid19tenquestions
AT bagherlarijani diabetesandcovid19tenquestions
_version_ 1724704801128710144